[HTML][HTML] Cellular and Humoral Responses in Dialysis Patients after Vaccination with the BNT162b2 or mRNA-1273 Vaccines

I Mavrovouniotis, A Fylaktou, M Stagou, K Ouranos… - Life, 2023 - mdpi.com
Simple Summary Patients with end-stage renal disease (ESRD) requiring hemodialysis
(HD) constitute a high-risk group in terms of susceptibility to and severity of infection. High …

[HTML][HTML] Maintenance of potent cellular and humoral immune responses in long-term hemodialysis patients after 1273-mRNA SARS-CoV-2 vaccination

M Gonzalez-Perez, J Baranda, MJ Berges-Buxeda… - Pharmaceuticals, 2023 - mdpi.com
Continuous evaluation of the coronavirus disease 2019 (COVID-19) vaccine effectiveness in
hemodialysis (HD) patients is critical in this immunocompromised patient group with higher …